Reactivation of chick-erythrocyte nuclei in heterokaryons (obtained by Sendai virus-induced fusion of chick erythrocytes with HeLa cells) is suppressed by specific inhibitors of trypsin and trypsin-like enzymes.
The mature chick erythrocyte contains a dormant nucleus, the replicative and transcriptional activities of its nuclear DNA having ceased during the latter stages of erythropoiesis. The nuclear chromatin of this end-stage cell is condensed and nucleoli are absent (1, 2) . When chick erythrocytes are fused with active cells (e.g., HeLa cells or fibroblasts) to form heterokaryons, the erythrocyte nucleus is reactivated (3, 4) . Shortly after cell fusion, the volume and dry mass of the erythrocyte nucleus increase, its tightly packed chromatin ("nuclear bodies") disperses, and RNA synthesis resumes. DNA replication begins 1-2 days after fusion, and nucleoli appear a day or two later (3) (4) (5) (6) (7) (8) .
The basis for reactivation of the dormant erythrocyte nucleus in heterokaryons is not understood. During Sendai virus-induced cell fusion the erythrocyte lyses and erythrocyte nuclei enter the cytoplasm of their partner cells without appreciable quantities of erythrocyte cytoplasm (3) (4) (5) (6) (7) (8) (9) . For this reason it is believed that factors present in partner cell cytoplasm reactivate erythrocyte nuclei (5, 6, 10) . We report here that certain inhibitors of proteolytic enzymes suppress reactivation of erythrocyte nuclei in heterokaryons. In addition, HeLa nuclei, ordinarily resistant to protease inhibitors, become sensitive to them when paired with chick-erythrocyte nuclei in heterokaryons, suggesting that they are sensitized by factors released by the erythrocyte nucleus. The results implicate cellular proteases in reactivation of chick-erythrocyte nuclei in heterokaryons.
Abbreviations: TLCK, N-a-tosyl-L-lysyl-chloromethane (trivial name: L-1-tosylamide-S2leucylchloromethylketone); TAME, Na-tosyl-L-arginine methylester; TPCK, N-a-tosyl-L-phenylalanylchloromethane (trivial name: L-1-tosylamide-2-phenyl-chloromethylketone); PheMeSF, phenyl-methyl sulfonyl fluoride; Me2SO , dimethylsulfoxide.
MATERIALS AND METHODS
Chick erythrocytes were obtained from 15-to 16-day-old embryos as described (7, 11) . HeLa cell cultures were maintained in Eagle's medium containing 10% fetal bovine serum and antibiotics (penicillin 100 u/ml; streptomycin 100 ,ug/ ml). Heterokaryons were prepared by fusion of chick erythrocytes with HeLa cells using UV-inactivated Sendai virus (800-1600 hemagglutinating units/ml) according to a technique described (7, 11 tion). Only heterokaryons containing one chick-erythrocyte nucleus and one HeLa nucleus were counted.
RESULTS Among the protease inhibitors tested, only TLCK and TAME exert significant effects on cell heterokaryons (Tables 1 and   2 ). In heterokaryons exposed to 0.1 mM TLCK for 48-hr in- Neither PheMeSF nor TPCK at concentrations of 0.1 mM or 0.01 mM, respectively, affect the heterokaryons. TPCK at a higher concentration (0.025 mM) produces rapid detachment of HeLa. cells and heterokaryons.
TLCK-and TAME-induced suppression of [3HJU and of [3H]dT incorporation by chick-erythrocyte nuclei in heterokaryons is observed 24 hr after cell fusion and is still evident at 48 hr (Fig. 1) . The extent to which incorporation of precursors in nuclei of heterokaryons is suppressed by TLCK varies with concentration (Fig. 2) 
DISCUSSION
The protease inhibitors TLCK and TAME have been shown in these experiments to inhibit reactivation (induction of RNA and DNA synthesis, nuclear enlargement) of chick-erythrocyte nuclei in heterokaryons at concentrations that affect individual HeLa cell nuclei or HeLa homokaryon nuclei minimally. TLCK and TAME inhibit trypsin and trypsin-like enzymes at concentrations comparable to those at which they suppressed chick-genome reactivation in the present studies. TLCK specifically alkylates histidine in the active center of trypsin; its action is irreversible. TAME is a reversible, substratetype inhibitor, preferred by trypsin-like enzymes (14) . TPCK, a chymotrypsin inhibitor, and PheMeSF, an inhibitor of esterases which phosphorylates serine residues in their active centers, were both inactive.
The active inhibitors are hydrophobic, lipid-soluble, and of low-molecular-weight. Accordingly, they probably penetrate the cell membrane, and thus, may act intracellularly. Little is known about intracellular proteases that might provide Cell Biology: Darzynkiewicz et al. a target for the inhibitors used in the present studies, although it is known that proteolytic activity can be demonstrated in isolated nuclei and in chromatin (15) (16) (17) . A nuclear protease(s) tightly associated with chromatin and with high specificity for individual histone fractions has been described and a role for it in hydrolysis of histones in vivo has been proposed (16, 17) . Unfortunately, its sensitivity to protease inhibitors has not been studied. If TLCK and TAME act specifically and intracellularly, it follows that intracellular proteases are implicated in reactivation of chick-erythrocyte nuclei. Possibly intracellular proteases remove suppressors involved in maintaining the condensed and dormant state of erythrocyte nuclear chromatin.
Certain additional data are in accord with this view. It has recently been observed that when an erythrocyte nucleus is paired with an active nucleus in a heterokaryon, RNA synthesis within the active-partner nucleus is to some extent depressed (8) . We confirm this observation (Table 1) In other cell systems, when the nuclear genome is activated, the extent to which actinomycin D binds to the nucleus increases (18) , and when the nuclear genome is suppressed, the extent to which actinomycin D binds to the nucleus falls (19- 23). Unmasking of DNA in nuclear chromatin is thought to permit binding of actinomycin D to newly accessible DNA sites during genome activation, and masking of DNA is held responsible for decreased actinomycin D binding to nuclear DNA during genome suppression (18) (19) (20) (21) (22) (23) (24) (1974) .--.--.-.
Therefore, the possibility that the inhibitors act by some alternative unknown mechanism cannot be excluded.
The chick erythrocyte is a highly differentiated, physiologically inactive end-cell with a dormant nucleus. Reactivation of its nucleus in heterokaryons may represent a unique situation, and the mechanisms involved in it need not be the same as those operating in regulation of transcription in more normal circumstances. However, we (25) , and others (26) , have observed that protease inhibitors suppress RNA synthesis in resting and stimulated lymphocytes. It is possible, therefore, that proteases, perhaps of nuclear location (15) (16) (17) , may be involved in regulation of transcription in eukaryotes.
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